Publications by the researcher in collaboration with MARÍA JOSÉ PARELLADA REDONDO (39)

2023

  1. Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study

    Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280

  2. Structural covariance predictors of clinical improvement at 2-year follow-up in first-episode psychosis

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 120

  3. Tobacco use in first-episode psychosis, a multinational EU-GEI study

    Psychological Medicine, Vol. 53, Núm. 15, pp. 7265-7276

2022

  1. How Executive Functions Correlate with Intelligence in Children and Adolescents in Autism Spectrum Disorders

    Journal of Cognition and Development, Vol. 23, Núm. 5, pp. 776-790

  2. Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val158Met polymorphism in first episode psychosis: Prefrontal abnormalities, executive dysfunction and symptoms severity

    Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 2, pp. 74-87

2021

  1. Fronto-parietal gray matter volume loss is associated with decreased working memory performance in adolescents with a first episode of psychosis

    Journal of Clinical Medicine, Vol. 10, Núm. 17

  2. The role of premorbid iq and age of onset as useful predictors of clinical, functional outcomes, and recovery of individuals with a first episode of psychosis

    Journal of Clinical Medicine, Vol. 10, Núm. 11

2020

  1. Premorbid Adjustment and IQ in Patients with First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship with Cannabis Use

    Schizophrenia Bulletin, Vol. 46, Núm. 3, pp. 517-529

  2. Social Cognition in Autism and Schizophrenia Spectrum Disorders: The Same but Different?

    Journal of Autism and Developmental Disorders, Vol. 50, Núm. 8, pp. 3046-3059

  3. The EUropean Network of National Schizophrenia Networks Studying Gene–Environment Interactions (EU-GEI): Incidence and First-Episode Case–Control Programme

    Social Psychiatry and Psychiatric Epidemiology, Vol. 55, Núm. 5, pp. 645-657

  4. The Positive and Negative Syndrome Scale for Schizophrenia Autism Severity Scale (PAUSS) in young people with autism and schizophrenia

    Revista de Psiquiatria y Salud Mental, Vol. 13, Núm. 3, pp. 118-130

2019

  1. Assessing cross-national invariance of the Community Assessment of Psychic Experiences (CAPE)

    Psychological Medicine, Vol. 49, Núm. 15, pp. 2600-2607

  2. Neutrophil count is associated with reduced gray matter and enlarged ventricles in first-episode psychosis

    Schizophrenia Bulletin, Vol. 45, Núm. 4, pp. 846-858

2018

  1. Smoking does not impact social and non-social cognition in patients with first episode psychosis

    Schizophrenia Research, Vol. 199, pp. 64-74

  2. Treated incidence of psychotic disorders in the multinational EU-GEI study

    JAMA Psychiatry, Vol. 75, Núm. 1, pp. 36-46

2017

  1. Atypical age-dependency of executive function and white matter microstructure in children and adolescents with autism spectrum disorders

    European Child and Adolescent Psychiatry, Vol. 26, Núm. 11, pp. 1361-1376

  2. Gene-environment interaction as a predictor of early adjustment in first episode psychosis

    Schizophrenia Research, Vol. 189, pp. 196-203

  3. Insular pathology in young people with high-functioning autism and first-episode psychosis

    Psychological Medicine, Vol. 47, Núm. 14, pp. 2472-2482

  4. Ir al médico sin miedo: www.doctortea.org para la habituación al entorno médico de pacientes con autismo

    Revista de Psiquiatria y Salud Mental, Vol. 10, Núm. 1, pp. 28-32

  5. Randomized trial of omega-3 for autism spectrum disorders: Effect on cell membrane composition and behavior

    European Neuropsychopharmacology, Vol. 27, Núm. 12, pp. 1319-1330